In the last couple of decades, the management of malignant bone tumor (MBT) has seen a sea change. With the advent in surgical technics, radiation therapy, and chemotherapy, it has moved from disabling amputation to limb salvage surgery. Extracorporeal irradiation (ECI) and re-implantation of resected bone is a useful method of limb salvage of MBTs. In our study, we analyzed and presented the results of 8 cases of MBTs treated with this modality. Between 2014 and 2017, 8 patients with primary MBT were enrolled for ECI technique who are meeting the eligibility criteria. Before taking the patient for ECI treatment, a multispecialty tumor board discussion was done for each patient. All of them received neo-adjuvant and adjuvant chemotherapy except the patients with histology of giant cell tumor. Following neoadjuvant chemotherapy bone excision surgery was performed, and the resected bone was taken for ECI with the dose of 50 Gray in a single fraction. After ECI, bone segment was re-implanted at osteotomy site in the same setting. After completion of adjuvant chemotherapy, the patients were then followed up for any sequelae, local and systemic control, ambulation, and functional outcome. Out of 8 patients, there were 5 males and 3 females with mean age of 22 (range 13-36). The involved bone was the tibia in 6 patients, ischium in 1 patient, and femur in 1 patient. Histopathologically, the malignancies included 3 osteosarcoma, 3 Giant cell tumor, 1 Ewing's sarcoma and 1 chondrosarcoma. At median follow-up of 12 months (range 6-26 months), local control rate was 87.5% and systemic control rate was 75%. Perioperative ECI and re-implantation is a useful, convenient, and inexpensive technique. The overall treatment time is reduced. The patient's own bone fits perfectly to the resection site with reduced risk of graft site infection. The risk of local recurrence due to tumor re-implantation is negligible with tumoricidal radiation doses of ECI, and it is usually associated with manageable sequelae. Recurrence rates are acceptable and salvageable with surgery.

Download full-text PDF

Source
http://dx.doi.org/10.4103/jcrt.jcrt_1316_21DOI Listing

Publication Analysis

Top Keywords

extracorporeal irradiation
8
bone
8
malignant bone
8
limb salvage
8
eci re-implantation
8
resected bone
8
adjuvant chemotherapy
8
chemotherapy patients
8
giant cell
8
cell tumor
8

Similar Publications

Thyroid-Targeted Nano-Bombs Empower HIFU for Graves' Disease.

Adv Sci (Weinh)

January 2025

The Department of Head and Neck Surgery, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China.

Graves' disease (GD) is an autoimmune disorder with a high incidence rate, particularly affecting women of reproductive age. Current treatment modalities for GD carry significant disadvantages, especially for pregnant or nursing women. As a novel extracorporeal therapeutic technique, high-intensity focused ultrasound (HIFU) shows great promise for treating GD; however, its low treatment efficacy impedes clinical application.

View Article and Find Full Text PDF

This study investigated whether intravenous administration of tumor cells killed by photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) had antitumor effects on distal tumors. Furthermore, a novel extracorporeal blood circulating 5-ALA/PDT system was developed. 5-ALA/PDT- (low or high irradiation) or anticancer drug-treated cells were intravenously administered to rats in a glioma cancer model.

View Article and Find Full Text PDF
Article Synopsis
  • Autologous blood obtained during surgical hardware reinfusion is often contaminated with bacteria, predominantly from skin microflora, in up to 90% of cases, posing a risk for infection.
  • Adding cefuroxime to the blood collection process was found to eliminate bacterial growth in 100% of instances when administered initially.
  • Despite various decontamination methods, including washing and leukocyte filtration, some bacterial contamination remained, though the combination of these techniques with cefuroxime significantly reduced the risk of bacterial presence in processed blood samples.
View Article and Find Full Text PDF

Background: Primary cardiac angiosarcomas are extremely rare and their prognosis is poor. Surgical resection is the first-line treatment; however, no clear standard of care has been clearly established because of the rarity of these tumors.

Case Presentation: A 61-year-old man who had presented with dyspnea on exertion was referred to our hospital.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the short-term effects of high-intensity laser therapy (HILT) and focused extracorporeal shockwave therapy (ESWT) on pain, sensitivity, handgrip strength, and function in treating lateral epicondylitis (LE) in 47 patients.
  • Participants were divided into two groups, receiving either HILT or ESWT three times a week for three weeks, along with exercises, and assessed using various measurement tools before, one week, and six weeks post-treatment.
  • Both treatments showed significant improvement in pain and functionality, but there were no significant differences between the groups in efficacy, indicating that both methods are effective and safe for short-term management of LE.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!